Compare stocks

Kuros Biosciences AG is a biotechnology company based in Switzerland, focused on the development of products for tissue repair and regeneration. Core to its business are biomaterial-based products designed to support bone healing in specific medical conditions. Its product portfolio includes innovative solutions like MagnetOs, used for spinal fusion; it is designed to enhance the body’s natural bone healing process. The company, headquartered in Schlieren, Switzerland, leverages its proprietary technologies to target significant unmet medical needs, positioning itself in the niche market of orthobiologics. Kuros Biosciences emphasizes innovation in biologics and synthetic solutions, aiming for a competitive edge in the healthcare sector.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.